180 related articles for article (PubMed ID: 32822816)
1. Interaction of non-coding RNAs and Hippo signaling: Implications for tumorigenesis.
Liu C; Wu Y; Ma J
Cancer Lett; 2020 Nov; 493():207-216. PubMed ID: 32822816
[TBL] [Abstract][Full Text] [Related]
2. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action.
Shi X; Zhu HR; Liu TT; Shen XZ; Zhu JM
Cancer Lett; 2017 Aug; 400():175-182. PubMed ID: 28461246
[TBL] [Abstract][Full Text] [Related]
3. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer.
Kim SH; Jin H; Meng RY; Kim DY; Liu YC; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547587
[TBL] [Abstract][Full Text] [Related]
4. The regulation and function of YAP transcription co-activator.
Zhu C; Li L; Zhao B
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
[TBL] [Abstract][Full Text] [Related]
5. The Emerging Link between the Hippo Pathway and Non-coding RNA.
Shimoda M; Moroishi T
Biol Pharm Bull; 2020; 43(1):1-10. PubMed ID: 31902912
[TBL] [Abstract][Full Text] [Related]
6. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Qin S; Mao Y; Wang H; Duan Y; Zhao L
Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
[TBL] [Abstract][Full Text] [Related]
7. The Hippo signaling pathway in liver regeneration and tumorigenesis.
Hong L; Cai Y; Jiang M; Zhou D; Chen L
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
[TBL] [Abstract][Full Text] [Related]
8. Circular RNAs modulate Hippo-YAP signaling: functional mechanisms in cancer.
Qadir J; Li F; Yang BB
Theranostics; 2022; 12(9):4269-4287. PubMed ID: 35673576
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression.
Zhang J; Liu H; Hou L; Wang G; Zhang R; Huang Y; Chen X; Zhu J
Mol Cancer; 2017 Sep; 16(1):151. PubMed ID: 28893265
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
Yang Y; Du Y; Liu X; Cho WC
Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
[TBL] [Abstract][Full Text] [Related]
11. Hippo signaling: a hub of growth control, tumor suppression and pluripotency maintenance.
Yin M; Zhang L
J Genet Genomics; 2011 Oct; 38(10):471-81. PubMed ID: 22035868
[TBL] [Abstract][Full Text] [Related]
12. MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker.
Jin X; Zhu L; Xiao S; Cui Z; Tang J; Yu J; Xie M
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760220
[TBL] [Abstract][Full Text] [Related]
13. Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs.
Sharma U; Tuli HS; Uttam V; Choudhary R; Sharma B; Sharma U; Prakash H; Jain A
Pharmacol Res; 2022 Dec; 186():106523. PubMed ID: 36377125
[TBL] [Abstract][Full Text] [Related]
14. Regulatory role of microRNAs in cancer through Hippo signaling pathway.
Astamal RV; Maghoul A; Taefehshokr S; Bagheri T; Mikaeili E; Derakhshani A; Delashoub M; Taefehshokr N; Isazadeh A; Hajazimian S; Tran A; Baradaran B
Pathol Res Pract; 2020 Dec; 216(12):153241. PubMed ID: 33065484
[TBL] [Abstract][Full Text] [Related]
15. New insights into the core Hippo signaling and biological macromolecules interactions in the biology of solid tumors.
Mohammadi S; Arefnezhad R; Danaii S; Yousefi M
Biofactors; 2020 Jul; 46(4):514-530. PubMed ID: 32445262
[TBL] [Abstract][Full Text] [Related]
16. Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.
Kyriazi AA; Papiris E; Kitsos Kalyvianakis K; Sakellaris G; Baritaki S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932969
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.
Huang Y; Yang Y; He Y; Li J
Tumour Biol; 2015 Dec; 36(12):9147-52. PubMed ID: 26427665
[TBL] [Abstract][Full Text] [Related]
18. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
Han Y; Tang Z; Zhao Y; Li Q; Wang E
Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
[TBL] [Abstract][Full Text] [Related]
19. Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway.
Deng J; Lei W; Xiang X; Zhang L; Lei J; Gong Y; Song M; Wang Y; Fang Z; Yu F; Feng M; Sun Z; Chen J; Zhan Z; Xiong J
Oncotarget; 2016 Mar; 7(9):10037-50. PubMed ID: 26840256
[TBL] [Abstract][Full Text] [Related]
20. 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway.
Li XJ; Park ES; Park MH; Kim SM
Oncol Rep; 2013 Nov; 30(5):2419-26. PubMed ID: 24008339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]